Resultados: 353

    Diagnostic testing for the monkeypox virus (MPXV): interim guidance

    This document provides interim guidance for clinicians, laboratories, health workers, public health officials and other stakeholders involved in the diagnosis and care of patients with suspected or confirmed mpox. This is an updated version of the interim guidance on Laboratory testing for the monkeypox ...

    Infection prevention and control guideline for Ebola and Marburg disease

    Ebola and Marburg disease outbreaks remain important public health threats. The newly published WHO Infection prevention and control guideline for Ebola and Marburg disease contains the Organization's most up to date recommendations for IPC measures to be implemented in all health facilities when caring ...

    WHO recommendations on induction of labour, at or beyond term

    The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this includes m...

    WHO recommendations on mechanical methods for induction of labour

    The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this includes m...

    WHO recommendation on tocolytic therapy for improving preterm birth outcomes

    In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of tocolysis as published in the WHO recommendations on interventions to improve preterm birth outco...

    WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes

    In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve pre...

    Clinical management of COVID-19: living guideline - 15 September 2022

    The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is impor...

    Guidelines on long-acting injectable cabotegravir for HIV prevention

    In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing...

    Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact

    As the HIV response moves to focusing on closing the remaining gaps in prevention, testing and treatment services, an evolution in the underlying routine data systems is needed to identify epidemiologic patterns and service gaps, and accelerate focused interventions. These guidelines focus on the collec...

    Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV

    Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released in 2018 ...